McKesson Analytics Explorer improves nationwide health systems
McKesson Analytics Explorer is improving clinical and financial outcomes at more than 30 health systems across the nation, McKesson said yesterday. Read More »
McKesson Analytics Explorer is improving clinical and financial outcomes at more than 30 health systems across the nation, McKesson said yesterday. Read More »
MyMedicineBox (MMB), India's first tele-pharmacy, has developed a new mobile app. The company said the app is designed to make it fast and easy for patients to manage their care, using their iPhones or Android phones, including reviewing test results and medical bills, managing prescriptions, learning about new products, scheduling doctor appointments and conducting video visits with an MMB pharmacist or doctor. Read More »
McKesson Health Solutions unveiled the latest edition of InterQual, the company's flagship decision-support software and technology system, on Monday. The 2015 edition includes 55 new and enhanced evidence-based clinical content areas and extensive updates, including the first admissions criteria to include comorbidities, criteria for 29 new specialty drugs and 33 new molecular diagnostic tests, as well as support for gene panels, among other features. Read More »
In 2014 the North American pharmacy information system market carried a value of more than $1.3 billion and its value is expected to increase to more than $2 billion by 2019, MicroMarket Monitor report said Monday. Pharmacy Information Systems (PIS) is an application used by medication dispensaries to increase patient safety by helping decrease the amount of errors in the dispensing process. It also provides information about dosage times and limits for specific patients based on their age, we Read More »
Pfizer Inc. on Wednesday announced two strategic appointments in the leadership of the Worldwide Research and Development organization. Read More »
New York is considering limiting the abilities of pharmacy benefit managers concerning maximum allowable costs for drugs. Two bills in committee, sponsored by Sen. Kemp Hannon and Assemblywoman Linda Rosenthal, would implement an appeals process for contracted pharmacies to dispute maximum allowable cost (MAC) schedules set by pharmacy benefit managers. Read More »
The Remedy Group will give a presentation titled “The Pitfalls to Growth and Maintaining the Patient Experience” at the 2015 Armada Specialty Pharmacy Summit. Read More »
State lawmakers around America have passed legislation limiting the competition among pharmacies, at the expense of consumers and pharmacy benefit managers, said Devon Herrick, senior fellow at the National Center for Policy Analysis. Read More »
Generational Equity announced yesterday that its client, Reuss Pharmacies Inc., was acquired by Lifecare Pharmacy. Read More »
The Pharmacy Benefit Management Institute (PBMI) today released the results of its 2015 PBM Customer Satisfaction Survey. Read More »
The Accreditation Commission for Health Care (ACHC) on Wednesday announced a newly formed partnership with the International Academy of Compounding Pharmacists (IACP). Read More »
Survey respondents say pain medication comes at higher cost, including stigmatization. Read More »
Parata Systems, a pharmacy technology solutions provider, said on Tuesday that it has appointed Emilie Ray to the Parata Board of Directors. "We are delighted Emilie has joined the board of directors," Parata CEO Tom Rhoads said. Read More »
Buck Consultants at Xerox released the findings from the 2014 annual “Prescription Drug Benefit Survey” which revealed that 77 percent employers spend 16 percent or more of their total healthcare budget on pharmacy benefits for employees and almost five percent of employers spend more than 30 percent on pharmacy. Read More »
Pfizer, Inc. recently named ExceleraRX Corp. to its limited drug distribution network. Read More »
Pfizer said on Friday that the U.S. Food and Drug Administration has agreed to review the New Drug Application (NDA) for ALO-02, an abuse-deterrent opioid for chronic pain. Read More »
Pfizer said on Wednesday that the U.S. Food and Drug Administration has accepted for review the supplemental New Drug Application (sNDA) for XELJANZ, a medication for treating moderate to severe chronic plaque psoriasis. Read More »